cis Element Decoy Against Nuclear Factor-κB Attenuates Development of Experimental Autoimmune Myocarditis in Rats

Author:

Yokoseki Osamu1,Suzuki Jun-ichi1,Kitabayashi Hiroshi1,Watanabe Noboru1,Wada Yuko1,Aoki Motokuni1,Morishita Ryuichi1,Kaneda Yasufumi1,Ogihara Toshio1,Futamatsu Hideki1,Kobayashi Yasushi1,Isobe Mitsuaki1

Affiliation:

1. From the Departments of Internal Medicine I (O.Y., J.S., H.K., N.W., M.I.) and Surgery II (Y.W.), Shinshu University School of Medicine, Nagano, Japan; the Division of Gene Therapy Science (M.A., R.M., Y.K.) and the Department of Geriatric Medicine (T.O.), Osaka University Graduate School of Medicine, Osaka, Japan; and the Department of Cardiovascular Medicine (H.F., Y.K., M.I.), Tokyo Medical and Dental University School of Medicine, Tokyo, Japan.

Abstract

Nuclear factor-κB (NFκB) plays a significant role in the coordinated transactivation of cytokine, inducible NO synthase (iNOS), and adhesion molecule genes. Although inflammation is an essential pathological feature of myocarditis, the role of NFκB in this process remains obscure. We examined the role of NFκB in the progression of rat experimental autoimmune myocarditis (EAM) and tested the hypothesis that NFκB blockade with a decoy against the cis element of NFκB can prevent the progression of EAM. Lewis rats were immunized with purified porcine cardiac myosin to establish EAM on day 0. NFκB decoy was infused into the rat coronary artery on day 0 (group NF0), 7 (group NF7), or 14 (group NF14) and harvested on day 21. Scrambled decoy was infused on day 0 (group SD0), 7 (group SD7), or 14 (group SD14) and served for control groups. The ratios of myocarditis-affected areas to the ventricular cross-sectional area of all treatment groups were significantly lower than those of the control groups (group NF0, 33±18% versus SD0, 53±14%; group NF7, 19±15% versus SD7, 50±16%; and group NF14, 34±10% versus SD14, 52±14%). Immunohistochemical and immunoblot analyses showed expression of ICAM-1, iNOS, IL-2, and TNFα in myocardium of scrambled decoy groups, and this expression was effectively suppressed by NFκB decoy treatment. Thus, we found that NFκB is a key regulator in the progression of EAM and that in vivo transfection of NFκB decoy reduces the severity of EAM.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3